Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Buchwald

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Endocrinology|October 22, 2019
Concentration-Dependency and Time Profile of Insulin Secretion: Dynamic Perifusion Studies With Human and Murine IsletsOscar Alcazar, Peter Buchwald
Theoretical Biology & Medical Modelling|March 29, 2006
The time-profile of cell growth in fission yeast: model selection criteria favoring bilinear models over exponential onesPeter Buchwald, Akos Sveiczer
Journal of Pharmaceutical Sciences|May 23, 2016
Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. BrewsterPeter Buchwald, Nicholas Bodor
Diabetologia|September 11, 2019
CD40-targeting KGYY<sub>15</sub> peptides do not efficiently block the CD40-CD40L interactionDamir Bojadzic, Peter Buchwald
Current Pharmaceutical Design|October 6, 2006
Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroidsNicholas Bodor, Peter Buchwald
Molecular Informatics|August 4, 2016
Bilinear Model for the Size-Dependency of the CYP3A4 Inhibitory Activity of Structurally Diverse CompoundsPeter Buchwald, Fumiyoshi Yamashita
Current Topics in Medicinal Chemistry|June 1, 2018
Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) InteractionsDamir Bojadzic, Peter Buchwald
Drug Discovery Today|January 28, 2003
Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's diseaseNicholas Bodor, Peter Buchwald
The AAPS Journal|April 6, 2006
Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systemsNicholas Bodor, Peter Buchwald
Molecular Biotechnology|February 7, 2004
Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolitesNicholas Bodor, Peter Buchwald
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Endocrinology|October 22, 2019
Concentration-Dependency and Time Profile of Insulin Secretion: Dynamic Perifusion Studies With Human and Murine IsletsOscar Alcazar, Peter Buchwald
Theoretical Biology & Medical Modelling|March 29, 2006
The time-profile of cell growth in fission yeast: model selection criteria favoring bilinear models over exponential onesPeter Buchwald, Akos Sveiczer
Journal of Pharmaceutical Sciences|May 23, 2016
Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. BrewsterPeter Buchwald, Nicholas Bodor
Diabetologia|September 11, 2019
CD40-targeting KGYY<sub>15</sub> peptides do not efficiently block the CD40-CD40L interactionDamir Bojadzic, Peter Buchwald
Current Pharmaceutical Design|October 6, 2006
Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroidsNicholas Bodor, Peter Buchwald
Molecular Informatics|August 4, 2016
Bilinear Model for the Size-Dependency of the CYP3A4 Inhibitory Activity of Structurally Diverse CompoundsPeter Buchwald, Fumiyoshi Yamashita
Current Topics in Medicinal Chemistry|June 1, 2018
Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) InteractionsDamir Bojadzic, Peter Buchwald
Drug Discovery Today|January 28, 2003
Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's diseaseNicholas Bodor, Peter Buchwald
The AAPS Journal|April 6, 2006
Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systemsNicholas Bodor, Peter Buchwald
Molecular Biotechnology|February 7, 2004
Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolitesNicholas Bodor, Peter Buchwald
Pageof 10